Dr. Georg A. BjarnasonDivision of Medical OncologySunnybrook Odette Cancer CentreAssociate Professor, Faculty of Medicine, University of Toronto discusses Dose Reduction or Treatment Interruption Pro: Treatment Interruption and individualized dose/schedule alterationIndividualized Sunitinib as an example? at the Kidney Cancer meeting in Chicago